Have your say on life sciences investment trends
LSX, formerly Biotech and Money, is conducting the 3rd Investor Perception ...
Read More
LSX, formerly Biotech and Money, is conducting the 3rd Investor Perception ...
Read MorePre-approval access is evolving at a rapid pace. Mark Corbett (pictured), E...
Read MoreKey learnings: Vesalius BioCapital III Partners invested €4 million in Finl...
Read MoreKey learnings: UK biotech Evox Therapeutics recently announced its £35.5 mi...
Read MoreThe development of new products in the life science industry is a very time...
Read MoreKey learnings: Leading US life sciences law firm Mintz has been active in t...
Read MoreUnderstand how to commercialise via partnering in Europe and other markets ...
Read MoreAccess to venture capital and effective fundraising tactics are key to buil...
Read MoreOne might think that planning for uncertainty is something that biotech fir...
Read MoreFor the first seven months of this year (to July) our Deal Watch analysis o...
Read MoreArtificial Intelligence (AI) systems hold great potential in taking on an i...
Read More
.jpg?t=1539952916573&width=20&name=Louise%20headshot%20-image1%20(2).jpg){kind=small}
Add Your Response